European Chemical Agency (ECHA) and Health and Safety Executive (HSE) Update: December 2024

ECHA Updates

Regulatory Management	Chemical	Defence Status
Harmonised Classification and Labelling: New Intentions	Sodium bromate No entry in CPR Annexes Muta and Carc (no class) (03.07.24)	Interest in defence TBC
	Cannabidiol (CBD) No entry in CPR Annexes Reprotox (no class)	No interest in defence
	Hydroxycitronellal Annex III entry 72 CMR 1B (repr)	Interest in defence TBC
	Padimate O Annex VI entry 21 CMR 1B (repr)	No interest in defence
	Diacetone alcohol no entry in CPR CMR 1B (legal deadline for opinion adoption 28.12.25)	No interest in defence
Harmonised Classification and Labelling: Dossier Submitted	Rosin, dimer rosin no entry in CPR Annexes CMR 1B (submitted 30.09.24)	Interest in defence TBC
Committee for Risk Assessment (RAC) Opinion Published	Heliotropine (Piperonal) No entry in CPR CMR 1B (repr) (opinion published)	Cosmetics Europe defence consortium
Committee for Risk Assessment (RAC) Opinion Published	Talc Annex III entry 59 of CPR CMR 1B (carc) (20.09.24) (RAC opinion published)	Defence TBC
REACH Restrictions	N/A	N/A
SVHC Classification and Authorisation	Triphenyl phosphate SVHC proposal (ED env) (07.11.24)	N/A
SVHC Classification and Authorisation	Trisiloxane No entry in CPR Annexes SVHC proposal (vPvB) (21.11.22)	N/A

HSE Updates

Regulatory Management	Chemical	Defence Status
Mandatory Classification and Labelling	O-phenylphenol (OPP) Final opinion published CMR 2 (reprotox)	Defence led by CTPA
	Tea tree oil and extract Technical report published CMR 1B (reprotox)	Defence under assessment
	Pentetic Acid proposed for CMR 1B (reprotox)	No interest in defence
	Pentasodium Pentetate proposed for CMR 1B (reprotox)	No interest in defence
REACH Restrictions	N/A	N/A
SVHC Classification and Authorisation	N/A	N/A